Skip to Content
MilliporeSigma

EHU026681

MISSION® esiRNA

targeting human TSPAN8

Slide 1 of 1
Sign In to View Organizational & Contract Pricing

Select a Size

20 μG

$242.00

50 μG

$435.00

$242.00

Usually ships in 3 weeks (4 to 6 weeks for custom orders).

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TGCTCCAGAGCATATTGCAGGACAAGCCTGTAACGAATAGTTAAATTCACGGCATCTGGATTCCTAATCCTTTTCCGAAATGGCAGGTGTGAGTGCCTGTATAAAATATTCTATGTTTACCTTCAACTTCTTGTTCTGGCTATGTGGTATCTTGATCCTAGCATTAGCAATATGGGTACGAGTAAGCAATGACTCTCAAGCAATTTTTGGTTCTGAAGATGTAGGCTCTAGCTCCTACGTTGCTGTGGACATATTGATTGCTGTAGGTGCCATCATCATGATTCTGGGCTTCCTGGGATGCTGCGGTGCTATAAAAGAAAGTCGCTGCATGCTTCTGTTGTTTTTCATAGGCTTGCTTCTGATCCTGCTCCTGCAGGTGGCGACAGGTATCCTAGGAGCTGTTTTCAAATCTAAGTCTGATCGCATTGTGAATGAAACTCTCTATGAAAACACAAAGCTTTTGAGCGCCACAGGGGAAAGTGAAAAA

Ensembl | human accession no.

ENSG00000127324

NCBI accession no.

NM_004616

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... TSPAN8(7103), TSPAN8(7103)

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
EHU016911EHU032601EHU105441
MISSION® esiRNA targeting human TSPAN8

Sigma-Aldrich

EHU026681

MISSION® esiRNA

MISSION® esiRNA targeting human TSPAN7, RP5-972B16.2

Sigma-Aldrich

EHU016911

MISSION® esiRNA

MISSION® esiRNA targeting human TSPAN9

Sigma-Aldrich

EHU032601

MISSION® esiRNA

MISSION® esiRNA targeting human TSPAN1

Sigma-Aldrich

EHU105441

MISSION® esiRNA

Gene Information

human ... TSPAN8(7103), TSPAN8(7103)

Gene Information

human ... TSPAN7(7102), TSPAN7(7102)

Gene Information

human ... TSPAN9(10867), TSPAN9(10867)

Gene Information

human ... TSPAN1(10103), TSPAN1(10103)

product line

MISSION®

product line

MISSION®

product line

MISSION®

product line

MISSION®

esiRNA cDNA target sequence

TGCTCCAGAGCATATTGCAGGACAAGCCTGTAACGAATAGTTAAATTCACGGCATCTGGATTCCTAATCCTTTTCCGAAATGGCAGGTGTGAGTGCCTGTATAAAATATTCTATGTTTACCTTCAACTTCTTGTTCTGGCTATGTGGTATCTTGATCCTAGCATTAGCAATATGGGTACGAGTAAGCAATGACTCTCAAGCAATTTTTGGTTCTGAAGATGTAGGCTCTAGCTCCTACGTTGCTGTGGACATATTGATTGCTGTAGGTGCCATCATCATGATTCTGGGCTTCCTGGGATGCTGCGGTGCTATAAAAGAAAGTCGCTGCATGCTTCTGTTGTTTTTCATAGGCTTGCTTCTGATCCTGCTCCTGCAGGTGGCGACAGGTATCCTAGGAGCTGTTTTCAAATCTAAGTCTGATCGCATTGTGAATGAAACTCTCTATGAAAACACAAAGCTTTTGAGCGCCACAGGGGAAAGTGAAAAA

esiRNA cDNA target sequence

CCTTATTGCCGAGAACTCCACAAATGCTCCCTATGTGCTCATCGGAACTGGCACCACTATTGTTGTCTTTGGCCTGTTTGGATGCTTTGCTACATGTCGTGGTAGCCCATGGATGCTGAAACTGTATGCCATGTTTCTGTCCCTGGTGTTCCTGGCTGAGCTCGTAGCTGGCATTTCAGGGTTTGTGTTTCGTCATGAGATCAAGGACACCTTCCTGAGGACTTACACGGACGCTATGCAGACTTACAATGGCAATGATGAGAGGAGCCGGGCAGTGGACCATGTGCAGCGCAGCCTGAGCTGCTGTGGTGTGCAGAACTACACCAACTGGAGCACCAGCCCCTACTTCCTGGAGCATGGCATCCCCCCCAGCTGCTGCATGAACGAAACTGATTGTAATCCCCAGGATCTACACAATCTGACTGTGGCCGCCACCAAAGTTAACCAGAAGGGTTGTTATGATCTGGTAACTAGTTTCATGGAGACTAACATGGGAATCATCGCTG

esiRNA cDNA target sequence

GCGGAATATCCTGGAACCTTCTTTTGTTTGTCAGCAGCCAAGGTGTTTCCAGGAAGTTCAGAGAGAACAGAATTTAAGAAGTGCAACATGGCCAGGGGCTGCCTCTGCTGCTTGAAGTACATGATGTTCCTCTTCAATTTGATATTCTGGCTCTGTGGCTGTGGGCTGCTGGGAGTGGGCATCTGGCTCTCCGTGTCCCAAGGCAACTTTGCCACCTTCTCCCCCAGCTTCCCTTCGTTGTCTGCAGCCAACCTGGTCATTGCCATAGGCACCATTGTCATGGTGACGGGCTTCCTCGGCTGCCTGGGGGCCATCAAGGAAAACAAGTGCCTCCTCCTCAGCTTTTTCATCGTCCTGTTGGTCATCCTCCTAGCAGAGCTGATCTTACTCATCCTCTTCTTTGTCTACATGGACAAGGTGAACGAGAACGCCAAGAAGGACCTGAAGGAAGGCCTGCTGCTGTACCACACCGAGAA

esiRNA cDNA target sequence

TGCAGTGCTTCAGCTTCATTAAGACCATGATGATCCTCTTCAATTTGCTCATCTTTCTGTGTGGTGCAGCCCTGTTGGCAGTGGGCATCTGGGTGTCAATCGATGGGGCATCCTTTCTGAAGATCTTCGGGCCACTGTCGTCCAGTGCCATGCAGTTTGTCAACGTGGGCTACTTCCTCATCGCAGCCGGCGTTGTGGTCTTTGCTCTTGGTTTCCTGGGCTGCTATGGTGCTAAGACTGAGAGCAAGTGTGCCCTCGTGACGTTCTTCTTCATCCTCCTCCTCATCTTCATTGCTGAGGTTGCAGCTGCTGTGGTCGCCTTGGTGTACACCACAATGGCTGAGCACTTCCTGACGTTGCTGGTAGTGCCTGCCATCAAGAAAGATTATGGTTCCCAGGAAGACTTCACTCAAGTGTGGAACACCACCATGAAAGGGCTCAAGTGCTGTGGCTTCACCAACTATACGGATTTTGAGGACTCACCCTACTTCAAAGAGAACAGTGCCTTTCCCCCATTCTGTTGCAATGACAACGTCACCAAC

Ensembl | human accession no.

ENSG00000127324

Ensembl | human accession no.

ENSG00000156298

Ensembl | human accession no.

ENSG00000011105

Ensembl | human accession no.

ENSG00000117472

NCBI accession no.

NM_004616

NCBI accession no.

NM_004615

NCBI accession no.

NM_006675

NCBI accession no.

NM_005727

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
QCS

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Manale El Kharbili et al.
Oncotarget, 8(10), 17140-17155 (2017-02-12)
Melanoma is well known for its propensity for lethal metastasis and resistance to most current therapies. Tumor progression and drug resistance depend to a large extent on the interplay between tumor cells and the surrounding matrix. We previously identified Tetraspanin
Manale El Kharbili et al.
Oncogene, 38(20), 3781-3793 (2019-01-27)
Due to its high proclivity to metastasize, and despite the recent development of targeted and immune therapy strategies, melanoma is still the deadliest form of skin cancer. Therefore, understanding the molecular mechanisms underlying melanoma invasion remains crucial. We previously characterized
Lunshou Wei et al.
International journal of clinical and experimental medicine, 8(6), 8599-8607 (2015-08-27)
This study was designed to investigate the effects of Tetraspanin 8 (TSPAN8) overexpression and TSPAN8 suppression on gastric cancer cell proliferation and invasion. Furthermore, whether extracellular-signal regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway was involved in TSPAN8's function on

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service